GC Aesthetics, a leading global breast implants company, today announced the completion of a $20 million Series D financing round. The financing included participation from existing investors Montreux Equity Partners, Oyster Capital, and Barry’s Tea Holdings.
GC Aesthetics will use the proceeds from this financing to accelerate growth to achieve its vision to become the leading breast implant company selling outside of the United States. It will continues to expand its commercial operations, launch its leading sixth generation product IMPLEO globally, invest in product innovation, and further improve customer service. GC Aesthetics, the parent company of UK-based Nagor and France-based Eurosilicone, produces more than 325,000 implants annually, which are marketed in over 75 countries. The company employs around 400 people globally.
Last year, GC Aesthetics grew its customer base by over 60% and experienced strong growth globally. The drivers of this customer growth include the quality and range of its products and the company’s focus on customer service through its We Care philosophy, which puts the needs of surgeons and customers at the heart of every decision.
“GC Aesthetics is making excellent progress in establishing itself as the leading breast implant provider in many markets globally. We are delighted to continue to work with a company that is progressing strongly on its vision to become the trusted brand in female aesthetics,”
said Daniel K. Turner III, Managing Director of Montreux Equity Partners.
The industry’s first-ever female chief executive, GC Aesthetics’ CEO Ayse Kocak, says of the new round of private financing:
“We are delighted with the continued support from our valued shareholders and are confident that their trust in GC Aesthetics will be rewarded by our continued expansion and growth. We are excited to receive this boost of capital to strengthen our position as one of the world’s leading breast implant manufacturers.”
About GC Aesthetics
GC Aesthetics is a leading female aesthetics company committed to becoming the trusted brand and partner for women seeking to look healthy, youthful, vibrant and beautiful, and to feel confident about themselves throughout their lifetime. The Company is focused on the development, manufacturing and commercialization of one of the broadest ranges of implant products, principally silicone breast implants. The Company has manufacturing facilities in the United Kingdom and France, and its implants are manufactured with medical-grade silicone supplied from ISO 9001-certified sources. GC Aesthetics is headquartered in Dublin.